Johnson & Johnson submits sNDA to FDA for Caplyta

Tuesday, Jul 8, 2025 8:03 am ET1min read

Johnson & Johnson submits sNDA to FDA for Caplyta

Comments



Add a public comment...
No comments

No comments yet